• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Plastin 3 protein mutations may be involved in osteoporosis

bys25qthea
October 18, 2013
in Chronic Disease, Genetics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. Pathogenic variants of the plastin 3 (PLS3) gene were identified in five families with X-linked osteoporosis and osteoporotic fractures.  

2. A rare PLS3 variant was found to be associated with decreased BMD and increased risk of fracture among elderly heterozygous women. 

3. Zebrafish with pls3 knockdown developed skeletal malformations that were reversible with administration of human PLS3 mRNA. 

Evidence Rating Level: 2 (Good) 

Study Rundown: Osteoporosis is a multifactorial disease with a complex pathophysiology involving both genetic and environmental factors. In this study, analyses of genomic data from families with X-linked osteoporosis led to the identification of several novel PLS3 gene variants. The study findings suggest that the PLS3 protein is important to bone health and that variants in its gene may have a role in multifactorial osteoporosis. The authors hypothesize that the PLS3 protein is important in the mechanosensitivity of osteocyte dendrites. Thus, mutations in PLS3 would result in decreased mechanosensing, leading to dysregulation of bone modeling or remodeling and ultimately to osteoporosis. The association between the rare PLS3 gene variant and osteoporosis was examined in a population of Dutch men and women. Additional studies with larger cohorts and greater ethnic variability are needed to further assess this relationship in the general population.

Click to read the study in NEJM

RELATED REPORTS

Association of potent topical corticosteroids and the risk of osteoporosis and major osteoporotic fractures

Bisphosphonate use and risk of atypical femur fractures

Delayed denosumab doses associated with increased the risk of vertebral fractures

Relevant Reading: Recent progress in understanding the genetic susceptibility to osteoporosis

In-Depth [prospective cohort study]: This study analyzed the genomes of families with X-linked osteoporosis and fractures without mutations in collagen type Iα1 or type Iα2 genes. Families 1 to 5 carried pathogenic variants for PLS3 and families 6 to 10 had been referred based on suspicion of osteogenesis imperfect type I. A single deleterious hemizygous frameshift in exon 3 of PLS3 was discovered through X-linked whole-exome sequencing of affected males from Family 1. Subsequent Sanger sequencing of all PLS3 exons in 95 affected male patients revealed four additional pathogenic variants in families 2 through 5 and a rare variant in families 6 through 10.

Genotyping for the rare variant was conducted in the three cohorts of the Rotterdam Study, a Dutch study analyzing the association of genetic factors with bone mineral density (BMD) and fractures. Heterozygous female carriers of the rare variant of PLS3 had significantly increased risk of fracture as compared to noncarriers. Fixed-effect model analysis of two of the cohorts found the odds ratio of fracture to be 1.95 (95% CI, 1.39 to 2.74; P<0.001). Combined analysis of the three Rotterdam Study cohorts showed a small but significantly decreased BMD at the lumbar spine and femoral neck in heterozygous women (P=0.008, and P=0.04, respectively). No significant difference was found in men.

In vivo studies of zebrafish found that PLS3 knockdown led to severe dysplasia of craniofacial skeletal elements. In addition, knockdown zebrafish larvae developed gross morphologic abnormalities that were specific and reversed dose-dependently with injections of human PLS3 mRNA.

By Xu Gao and Adrienne Cheung

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: osteoporosisPLS3
Previous Post

Sham procedures effective in generating placebo effect among migraine patients

Next Post

Frey procedure may yield better outcomes in chronic pancreatitis

RelatedReports

Eczema more prevalent among older adults than previously thought
Chronic Disease

Association of potent topical corticosteroids and the risk of osteoporosis and major osteoporotic fractures

January 27, 2021
Bisphosphonate use and risk of atypical femur fractures
Chronic Disease

Bisphosphonate use and risk of atypical femur fractures

August 26, 2020
Vitamin D supplementation amongst post-menopausal women did not improve functional outcomes
Chronic Disease

Delayed denosumab doses associated with increased the risk of vertebral fractures

July 30, 2020
Vitamin D supplementation amongst post-menopausal women did not improve functional outcomes
Cardiology

Direct oral anticoagulants associated with lower risk of osteoporotic fracture versus warfarin

May 19, 2020
Next Post
Wound surgical device found ineffective at infection control: ROSSINI Trial

Frey procedure may yield better outcomes in chronic pancreatitis

Motion Displacement Test is accurate in screening for glaucoma

One-year of Herceptin preferable to two-year regimen

Age, cardiac comorbidities linked to increased risk of trastuzumab-related CHF

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Long-acting cabotegravir significantly decreases incidence of HIV compared to daily oral tenofovir
  • Oral methylprednisolone may reduce risk of progressive renal failure in patients with IgA nephropathy: TESTING Trial
  • #VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.